The German National Immune Tolerance Registry, 1997 update

Vox Sanguinis

Volumn 77, Issue SUPPL. 1, 1999, Pages 28-30

  Lenk, H ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 INHIBITOR; BLOOD CLOTTING FACTOR 9; RECOMBINANT BLOOD CLOTTING FACTOR 8;

ADOLESCENT; ADULT; CHILD; CONFERENCE PAPER; GERMANY; HEMOPHILIA; HUMAN; IMMUNOLOGICAL TOLERANCE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REGISTER; TIME; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; FACTOR IX; FACTOR VIII; GERMANY; HEMOPHILIA A; HUMANS; IMMUNE TOLERANCE; INFANT; ISOANTIBODIES; MIDDLE AGED; REGISTRIES; REGRESSION ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 0032875191     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1159/000056711     Document Type: Conference Paper

References (4)

1. Brackmann HH: Induced immune tolerance in factor VIII inhibitor patients. Prog Clin Biol Res 1984;150:181-195.
2. Lenk H, Brackmann HH, Scharrer I, Kreuz W: Immuntoleranztherapie der Hämophilie A - Ergebnisse und Empfehlungen; in Scharrer I, Schramm W. 25. Hämophilie Symposium Hamburg. Berlin-Heidelberg, Springer Verlag, 1996, pp 263-267.
3. Lusher J, Mariani G: Protocols, dosages and clinical aspects of immune tolerance. Vox Sang 1996;70(suppl 1):60-65.
4. Mariani G, Hilgartner M, Thompson AR, Manco-Johnson M, Brackmann HH: For the participants in the International Registry of immune tolerance protocols. Immune tolerance to factor VIII: The international registry data. New York, Plenum Press, 1995, pp 201-208.